A Phase II Study of Amivantamab SC (subcutaneous) in Participants with MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)
| Protocol No. | CTO-S1900J | Scope | National |
|---|---|---|---|
| Principal Investigator | Rohan Maniar | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
